Search results
Results from the WOW.Com Content Network
In August 2012 Mexico achieved universal healthcare coverage. [79] However, a 2023 article published by the Council on Foreign Relations stated "Mexico is a study in contrasts: once a model for how to do health system reform, now a model of what not to do" and reported that Seguro Popular was eliminated without a replacement. [80]
This is a list of notable academic journals about nursing.. AACN Advanced Critical Care; AACN Nursing Scan in Critical Care; Advances in Neonatal Care; American Journal of Critical Care
Sometimes the term safety ratio is used, particularly when referring to psychoactive drugs used for non-therapeutic purposes, e.g. recreational use. [10] In such cases, the effective dose is the amount and frequency that produces the desired effect, which can vary, and can be greater or less than the therapeutically effective dose.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
NANDA International (formerly the North American Nursing Diagnosis Association) is a professional organization of nurses interested in standardized nursing terminology, that was officially founded in 1982 and develops, researches, disseminates and refines the nomenclature, criteria, and taxonomy of nursing diagnosis. In 2002, NANDA became NANDA ...
The ratios The Senate bill outlines specific minimum staffing standards for various units, which are 1-to-1 ratios of 1 registered nurse to 1 patient for critical care patients in the emergency ...
The Federico Gomez public children's hospital in the Doctores neighborhood of Mexico City will have to cut its supply of anesthesia and nitric oxide by half as of June 1, according to a document ...
In combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth-factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant ...